DEA Schedule CV
Strength
100 mg/1
Manufacturer
UCB, Inc.NDC
50474077066
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
BRIVARACETAMApproval Type
New Drug (NDA)
FDA Application
NDA205836On Market Since
5/12/2016
Pharmacological Classes
Epoxide Hydrolase Inhibitors
Related Drugs
Same classification
No related drugs found.